Literature DB >> 3884502

Postprandial hyperinsulinemia in patients with mild essential hypertension.

P Singer, W Gödicke, S Voigt, I Hajdu, M Weiss.   

Abstract

Glucose tolerance tests and diurnal profiles of glucose, insulin, free fatty acids, serum triglycerides, total and high-density lipoprotein cholesterol levels were performed in 8 male patients with mild essential hypertension as well as in 20 normotensive subjects. Although glucose tolerance and postprandial glucose levels appeared equal in both groups, the insulin response after a glucose load and after each meal was significantly increased in hypertensive subjects as compared with the controls (p less than 0.01). The levels of free fatty acids were higher in the postabsorptive phase of patients with hypertension in comparison to normotensive subjects, but decreased markedly when plasma insulin levels rose after meals. In both subject groups serum triglyceride levels showed the typical postprandial increase. Total and high-density lipoprotein cholesterol levels showed neither diurnal variations nor differences between hypertensive subjects and normotensive controls. Postprandial hyperinsulinemia in patients with mild essential hypertension possibly may provoke lipid accumulation in the arterial wall and therefore may be a relevant risk factor for atherosclerosis in these subjects.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3884502     DOI: 10.1161/01.hyp.7.2.182

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  24 in total

1.  Palmitic acid acutely stimulates glucose uptake via activation of Akt and ERK1/2 in skeletal muscle cells.

Authors:  Jing Pu; Gong Peng; Linghai Li; Huimin Na; Yanbo Liu; Pingsheng Liu
Journal:  J Lipid Res       Date:  2011-04-25       Impact factor: 5.922

Review 2.  Hypertension.

Authors:  G W Ching; D G Beevers
Journal:  Postgrad Med J       Date:  1991-03       Impact factor: 2.401

Review 3.  Diabetic nephropathy. Its relationship to hypertension and means of pharmacological intervention.

Authors:  T Baba; S Neugebauer; T Watanabe
Journal:  Drugs       Date:  1997-08       Impact factor: 9.546

Review 4.  Coronary heart disease in diabetes mellitus--antecedents and associations.

Authors:  P H Winocour
Journal:  Postgrad Med J       Date:  1991-10       Impact factor: 2.401

Review 5.  Insulin resistance and hypertension--implications for treatment.

Authors:  P A Rutherford; T H Thomas; R Wilkinson
Journal:  Postgrad Med J       Date:  1991-10       Impact factor: 2.401

Review 6.  Recent Advances in Pharmacological Management of Hypertension in Diabetic Patients with Nephropathy : Effects of Antihypertensive Drugs on Kidney Function and Insulin Sensitivity.

Authors:  Tsuneharu Baba; Takashi Ishizaki
Journal:  Drugs       Date:  1992-04       Impact factor: 9.546

Review 7.  Diabetes and atherosclerosis. Metabolic links.

Authors:  G Steiner
Journal:  Drugs       Date:  1988       Impact factor: 9.546

Review 8.  Hyperinsulinemia, hyperproinsulinemia and insulin resistance in the metabolic syndrome.

Authors:  J Schrezenmeir
Journal:  Experientia       Date:  1996-05-15

9.  Hyperinsulinemia in hypertension: increased secretion, reduced clearance or both?

Authors:  D Giugliano; A Quatraro; A Minei; N De Rosa; L Coppola; F D'Onofrio
Journal:  J Endocrinol Invest       Date:  1993-05       Impact factor: 4.256

10.  Hemostatic risk factors in patients with coronary artery disease and type 2 diabetes - a two year follow-up of 243 patients.

Authors:  Thomas W Jax; Ansgar J Peters; Gunnar Plehn; Frank-Chris Schoebel
Journal:  Cardiovasc Diabetol       Date:  2009-09-07       Impact factor: 9.951

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.